Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis

S. A. Harrison, S. R. Marri, N. Chalasani, R. Kohli, W. Aronstein, G. A. Thompson, W. Irish, M. V. Miles, S. A. Xanthakos, E. Lawitz, M. Noureddin, T. D. Schiano, M. Siddiqui, A. Sanyal, B. A. Neuschwander-Tetri, P. G. Traber

Research output: Contribution to journalArticlepeer-review

139 Scopus citations

Fingerprint

Dive into the research topics of 'Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science